Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF JULY 30, 2015 FBO #4997
SOURCES SOUGHT

66 -- REQ 1146975--NOTICE OF INTENT TO SOLE SOURCE

Notice Date
7/28/2015
 
Notice Type
Sources Sought
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
 
ZIP Code
20857-0001
 
Solicitation Number
FDA-15-SS-1146975
 
Archive Date
8/20/2015
 
Point of Contact
Marty F. Nemec, Phone: 2404027663
 
E-Mail Address
marty.nemec@fda.hhs.gov
(marty.nemec@fda.hhs.gov)
 
Small Business Set-Aside
N/A
 
Description
FDA 1146975 Notice of Intent; Brand Name Only - Gilson, Inc. The Food and Drug Administration intends to award a Sole Source firm-fixed price contract to Gilson, Inc., 3000 Parmenter Street, Middleton, WI, 53562 in accordance with FAR part 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. This procurement is being conducted under simplified acquisitions procedures in accordance with FAR Parts 12 and 13. The NAICS code is 334516, ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING. The purpose of this acquisition is to procure a piece of automatic solid phase extraction equipment to replace the labor-intensive liquid-liquid extraction or the tedious manual solid phase extraction process currently in use. This equipment will be used in all of Northeast Regional Laboratory's chemotherapeutic programs. Northeast Regional Laboratory requires the ability to replicate experiments performed by Arkansas Regional Laboratory, which used the Gilson GTX-274 ASPEC solid phase extractor for their experiments. For this reason, this piece of equipment to be procured must be the Gilson GTX-274 ASPEC solid phase extractor. This notice is not a request for competitive quotes. However, any party that believes it is capable of meeting the requirements as stated herein may submit a written response, i.e. capability statement, which clearly supports and demonstrates its ability to perform the requirements. Any response shall be received by the response date and time of this notice. Any response shall undergo review to determine if it can meet the requirements. A determination by the Government not to compete this proposed contract based upon a response to this notice is solely within the discretion of the Government. Response Date: 4:00 p.m. ET on August 5, 2015. Please email responses to Marty Nemec at marty.nemec@fda.hhs.gov.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-15-SS-1146975/listing.html)
 
Place of Performance
Address: FDA/Northeast Regional Laboratory, 158-15 Liberty Avenue, Jamaica, New York, 11433, United States
Zip Code: 11433
 
Record
SN03812900-W 20150730/150728235351-2d053a813fdecad53e04d1eb648105e0 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.